Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Michelle Teng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Medical College of Wisconsin, Suite C410, Children Corporate Center, 999N 92nd Street, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Oxidative Stress, Inflammation. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NHLBI.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is the most common lung complication of prematurity. Despite extensive research, our understanding of its pathophysiology remains limited, as reflected by the stable prevalence of BPD. Prematurity is the primary risk factor for BPD, with oxidative stress (OS) and inflammation playing significant roles and being closely linked to premature birth. Understanding the interplay and temporal relationship between OS and inflammation is crucial for developing new treatments for BPD. Animal studies suggest that OS and inflammation can exacerbate each other. Clinical trials focusing solely on antioxidants or anti-inflammatory therapies have been unsuccessful. In contrast, vitamin A and caffeine, with antioxidant and anti-inflammatory properties, have shown some efficacy, reducing BPD by about 10%. However, more than one-third of very preterm infants still suffer from BPD. New therapeutic agents are needed. A novel tripeptide, N-acetyl-lysyltyrosylcysteine amide (KYC), is a reversible myeloperoxidase inhibitor and a systems pharmacology agent. It reduces BPD severity by inhibiting MPO, enhancing antioxidative proteins, and alleviating endoplasmic reticulum stress and cellular senescence in a hyperoxia rat model. KYC represents a promising new approach to BPD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Medical College of Wisconsin, Suite C410, Children Corporate Center, 999N 92nd Street, Milwaukee, WI 53226, USA.
- Children's Research Institute, Medical College of Wisconsin, 8701 W Watertown Plank Rd., Wauwatosa, WI 53226, USA.
- ReNeuroGen LLC, 2160 San Fernando Dr., Elm Grove, WI 53122, USA.
- Department of Surgery, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
ORCID-Profile: Billy W Day, Kirkwood A Pritchard, Stephen Naylor, Ru-Jeng Teng
Förderung
- NHLBI NIH HHS
- NHLBI
Zitieren
APA
Teng, M., Wu, T. J., Jing, X., Day, B. W., Pritchard, K. A., Naylor, S., & Teng, R. J. (2024). Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810145
Vancouver
Teng M, Wu TJ, Jing X, Day BW, Pritchard KA, Naylor S, et al. Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810145
BibTeX
@article{Teng2024,
author = {Teng, Michelle and Wu, Tzong-Jin and Jing, Xigang and Day, Billy W and Pritchard, Kirkwood A and Naylor, Stephen and Teng, Ru-Jeng},
title = {Temporal Dynamics of Oxidative Stress and Inflammation in Bronchopulmonary Dysplasia},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810145}
}
EUVIMED